Gene therapy for arthritis

References

• Tomita T, Hashimoto H, Tomita N, Morishita R, Lee SB, Hayashida K, et al. In vivo direct gene transfer into articular cartilage by intraarticular injection mediated by HVJ (Sendai virus) and liposomes. Arthritis Rheum 1997;40:901–6.
   PubMed Web of Science ®Google Scholar
• Tomita T, Takeuchi E, Tomita N, Morishita R, Kaneko M, Yamamoto K, et al. Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kB decoy oligonucleotides as a gene therapy. Arthritis Rheum 1999;42:2532–42.
   PubMed Web of Science ®Google Scholar
• Miyasaka N, Sato K, Goto M, Sasano M, Natsuyama M, Inoue K, et al. Augmented interleukin-1 production and HLA-DR ex-pression in the synovium of rheumatoid arthritis patients. Possible involvement in joint destruction. Arthritis Rheum 1988;31:480–
   PubMed Web of Science ®Google Scholar
• Whalen JD, Lechman EL, Carlos CA, Weiss K, Kovesdi I, Glorioso JC, et al. Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws. J Immunol 1999;162:3625–32.
   PubMed Web of Science ®Google Scholar
• Makarov SS, Olsen JC, Johnston WN, Anderle SK, Brown RR, Baldwin AJ, et al. Suppression of experimental arthritis by gene transfer of interleukin-1 receptor antagonist cDNA. Proc Natl Acad Sci USA 1996;93:402–6.
   PubMed Web of Science ®Google Scholar
• Bakker AC, Joosten LA, Arntz OJ, Helsen MM, Bendele AM, et al. Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee. Arthritis Rheum 1997;40:893–900.
   PubMed Web of Science ®Google Scholar
• Otani K, Nita I, Macaulay W, Georgescu HI, Robbins PD, Evans CH. Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy. J Immunol 1996;156:3558–62.
   PubMed Web of Science ®Google Scholar
• Pelletier JP, Caron JP, Evans C, Robbins PD, Georgescu HI, Jovanovic D, et al. In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy. Arthritis Rheum 1997;40:1012–9.
   PubMed Web of Science ®Google Scholar
• Milner-Ladner U, Roberts CR, Franklin BN, Gay RE, Robbins PD, Evans CH, et al. Human IL-1Ra gene transfer into human synovial fibroblasts is chondroprotective. J Immunol 1997;158: 3492–8.
   Google Scholar
• Evans CH, Robbins PD, Ghivizzani SC, Herndon JH, Kang R, Bahnson AB, et al. Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. Hum Gene Ther 1996;7: 1261–80.
   PubMed Web of Science ®Google Scholar
• Apparailly F, Verwaerde C, Jacquet C, Auriault C, Sany J, Jorgensen C. Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis. J Immunol 1998;160: 5213–20.
   PubMed Web of Science ®Google Scholar
• Lechman ER, Jaffurs D, Ghivizzani SC, Gambotto A, Kovesdi I, Mi Z, et al. Direct adenoviral gene transfer of viral IL-10 to rabbit knees with experimental arthritis ameliorates disease in both injected and contralateral control knees. J Immunol 1999;163: 2202–8.
   PubMed Web of Science ®Google Scholar
• Ma Y, Thornton S, Duwel LE, Boivin GP, Giannini EH, Leiden JM, et al. Inhibition of collagen-induced arthritis in mice by viral IL-10 gene transfer. J Immunol 1998;161:1516–24.
   PubMedGoogle Scholar
• Cush JJ, Splawski JB, Thomas R, McFarlin JE, Schulze KH, Davis LS, et al. Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum 1995;38:96–104.
   PubMed Web of Science ®Google Scholar
• Katsikis PD, Chu CQ, Brennan FM, Maini RN, Feldmann M. Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 1994;179: 1517–27.
   Google Scholar
• Song XY, Gu M, Jin WW, Klinman DM, Wahl SM. Plasmid DNA encoding transforming growth factor-p1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model. J Chin Invest 1998;101: 2615–21.
   Google Scholar
• Fava RA, Olsen NJ, Postlethwaite AE, Broadley KN, Davidson JM, Nanney LB, et al. Transforming growth factor (31 (TGF-p1)-induced neutrophil recruitment to synovial tissues: implications for TGF-beta-driven synovial inflammation and hyperplasia. J Exp Med 1991;173:1121–32.
   PubMed Web of Science ®Google Scholar
• Le CH, Nicolson AG, Morales A, Sewell KL. Suppression of collagen-induced arthritis through adenovirus-mediated transfer of a modified tumor necrosis factor a receptor gene. Arthritis Rheum 1997;40:1662–9.
   PubMed Web of Science ®Google Scholar
• Takayanagi H, Juji T, Miyazaki T, Iizuka H, Takahashi T, Isshiki M, et al. Suppression of arthritic bone destruction by adenovirus-mediated csk gene transfer to synoviocytes and osteoclasts. J Chin Invest 1999;104:137–46.
   PubMed Web of Science ®Google Scholar
• Okamoto K, Asahara H, Kobayashi T, Matsuno H, Hasunuma T, Kobata T, et al. Induction of apoptosis in the rheumatoid synovium by Fas ligand gene transfer. Gene Ther 1998;5:331–8.
   PubMed Web of Science ®Google Scholar
• Zhang H, Yang Y, Horton JL, Samoilova EB, Judge TA, Turka LA, et al. Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer. J Chin Invest 1997;100:1951–7.
   PubMedGoogle Scholar
• Rabinovich GA, Daly G, Dreja H, Tailor H, Ftiera CM, Hirabayashi J, et al. Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J Exp Med 1999;190:385–98.
   PubMed Web of Science ®Google Scholar
• Persson S, Mikulowska A, Narula S, O'Garra A, Holmdahl R. Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats. Scand J Immunol 1996;44: 607–14.
   Google Scholar
• Joosten LA, Lubberts E, Durez P, Helsen MM, Jacobs MJ, Goldman M, et al. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum 1997;40:249–60.
   Google Scholar
• Firestein GS, Yeo M, Zvaifler NJ. Apoptosis in rheumatoid arthritis synovium. J Clin Invest 1995;96:1631–8.
   PubMed Web of Science ®Google Scholar
• Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995;9:1149–63.
   PubMed Web of Science ®Google Scholar
• Taniguchi K, Kohsaka H, Inoue N, Terada Y, Ito H, Hirokawa K, et al. Induction of the pl6INK4a senescence gene as a new therapeutic strategy for the treatment of rheumatoid arthritis. Nat Med 1999;5:760–7.
   PubMed Web of Science ®Google Scholar
• Lois AF, Cooper LT, Geng Y, Nobori T, Carson DA. Expression of the p16 and p15 cyclin-dependent kinase inhibitors in lymphocyte activation and neuronal differentiation. Cancer Res 1995;55: 4010–3.
   Google Scholar
• Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D, Barrett JC. Involvement of the cyclin-dependent kinase inhibitor pl6INK4a in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci USA 1996;93:13742–7.
   PubMed Web of Science ®Google Scholar
• Kato D, Miyazawa K, Ruas M, Starborg M, Wada I, Oka T, et al. Features of replicative senescence induced by direct addition of antennapedia-pl6INK4A fusion protein to human diploid fibroblasts. FEBS Lett 1998;427:203–8.
   PubMed Web of Science ®Google Scholar
• Uhrbom L, Nistér M, Westermark B. Induction of senescence in human malignant glioma cells by p16INK4A. Oncogene 1997;15:505–14.
   PubMedGoogle Scholar
• Fueyo J, Gomez MC, Yung WK, Clayman GL, Liu TJ, Bruner J, et al. Adenovirus-mediated p16/CDKN2 gene transfer induces growth arrest and modifies the transformed phenotype of glioma cells. Oncogene 1996;12:103–10.
   PubMed Web of Science ®Google Scholar
• Bondeson J, Foxwell B, Brennan F, Feldmann M. Defining therapeutic targets by using adenovirus: blocking NF-KB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators. Proc Natl Acad Sci USA 1999;96:5668–73.
   PubMed Web of Science ®Google Scholar
• Foxwell B, Browne K, Bondeson J, Clarke C de MR, Brennan F, et al. Efficient adenoviral infection with IxBa reveals that macro-phage tumor necrosis factor a production in rheumatoid arthritis is NF-KB dependent. Proc Natl Acad Sci USA 1998;95:8211–5.
   Google Scholar